Speaker illustration

Mr Anirudh Suresh

Chelsea and Westminster Hospital NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipid-Lowering Agents

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb